ABSTRACT Bacteria that express contact-dependent growth inhibition (CDI) systems outcompete siblings that lack immunity, suggesting that CDI mediates intercellular competition. To further explore the role of CDI in competition, we determined the target cell range of the CDI EC93 system from Escherichia coli EC93. The CdiA EC93 effector protein recognizes the widely conserved BamA protein as a receptor, yet E. coli EC93 does not inhibit other enterobacterial species. The predicted membrane topology of BamA indicates that three of its extracellular loops vary considerably between species, suggesting that loop heterogeneity may control CDI specificity. Consistent with this hypothesis, other enterobacteria are sensitized to CDI EC93 upon the expression of E. coli bamA and E. coli cells become CDI EC93 resistant when bamA is replaced with alleles from other species. Our data indicate that BamA loops 6 and 7 form the CdiA EC93 -binding epitope and their variation between species restricts CDI EC93 target cell selection. Although BamA loops 6 and 7 vary dramatically between species, these regions are identical in hundreds of E. coli strains, suggesting that BamA Ecoli and CdiA EC93 play a role in self-nonself discrimination.
to CDI EC93 (10) . BamA plays a critical role in cell-cell adhesion during CDI EC93 , and binding interactions between inhibitor and target cells are blocked by anti-BamA antibodies (10) . Anti-BamA antibodies also protect target cells from CDI EC93 -mediated growth inhibition. These observations suggest that BamA is the receptor for CdiA EC93 . Additionally, acrB null mutations confer resistance to CDI EC93 (10) . AcrB is a trimeric inner membrane protein that functions together with AcrA and TolC as a multidrug efflux pump (17, 18) . However, acrA and tolC mutants have no resistance phenotype (10) , indicating that the role of AcrB in CDI EC93 is distinct from its efflux function. The localization of AcrB suggests that this protein could facilitate CdiA-CT EC93 insertion into the membrane or perhaps stabilize the pore once assembled. Together, these studies have led to a model postulating that the CdiA EC93 effector exploits specific cell envelope proteins to deliver and activate its toxin domain.
E. coli EC93 inhibits a variety of E. coli strains (1, 5, 10) , but its activity against other bacterial species has not been examined. BamA and AcrB are both well conserved among enterobacteria, raising the possibility that E. coli EC93 could inhibit other species. However, we find that the growth of Salmonella enterica serovar Typhimurium, Citrobacter freundii, Enterobacter aerogenes, Enterobacter cloacae, and Proteus mirabilis cells is not inhibited during coculture with E. coli EC93. BamA from these enterobacteria has 73% to 93% sequence identity with E. coli BamA, but sequence differences are concentrated within three of the predicted extracellular loops. These observations suggest that CdiA EC93 is unable to bind BamA from other species because of surface residue variability. In accord with this hypothesis, expression of E. coli bamA sensitizes other species to CDI EC93 . Furthermore, replacement of the E. coli bamA gene with alleles from other species renders cells resistant to inhibition. Using chimeric receptors, we localized the CdiA EC93 -binding region to extracellular loops 6 and 7 of E. coli
BamA. These findings demonstrate that CDI EC93 is restricted at the level of target cell selection and suggest that CDI may function more broadly in kin selection.
RESULTS
Diverse enterobacteria are resistant to CDI EC93 . To test whether CDI EC93 exhibits cross-species inhibition activity, we examined the growth of Enterobacter aerogenes (ATCC 13048), Enterobacter cloacae (ATCC 13047), Citrobacter freundii (ATCC 8090), Proteus mirabilis (ATCC 7002), and Salmonella Typhimurium LT2 cells in cocultures with E. coli EC93. E. coli EC93 cells were suspended with target bacteria at a 10:1 ratio, and the suspension was plated onto LB agar at high density to facilitate cell-cell contact. Under these conditions, viable E. coli MC4100 target cell counts decreased 150-fold after 20 h of coculture with E. coli EC93 (Fig. 1 ). This inhibition is attributable to CDI EC93 because E. coli MC4100 cell counts increased 6-fold in mock competitions with E. coli EC93 ⌬cdiA mutant cells (Fig. 1) . In contrast, all other target species grew to about the same cell density when cocultured with wild-type E. coli EC93 (CDI ϩ ) or the E. coli EC93 ⌬cdiA mutant (CDI Ϫ ) (Fig. 1) . Thus, other species are resistant to CDI EC93 , suggesting that E. coli EC93 only inhibits related E. coli strains. We also measured E. coli EC93 growth during interspecies competition and found that cell counts increased 9-fold to 50-fold in all cocultures except those with E. cloacae, in which E. coli EC93 cells did not increase significantly (see Fig. S1 in the supplemental material). Because the cultures were seeded with 10-fold more E. coli EC93 cells, the latter data suggest that E. cloacae ATCC 13047 inhibits E. coli EC93.
E. coli bamA sensitizes other enterobacterial species to CDI EC93 . Mutations that decrease bamA or acrB expression confer CDI EC93 resistance on E. coli cells (10) . Each of the tested target species contains bamA and acrB genes that are homologous to but distinct from those of E. coli (see Fig. S2 and S3 in the supplemental material). Therefore, we tested whether E. coli alleles of bamA (bamA Ecoli ) and acrB (acrB Ecoli ) are required for susceptibility to CDI EC93 . We introduced plasmids (see Text S1 in the supplemental material) carrying either bamA Ecoli (pZS21-bamA ϩ ) or acrB Ecoli (pacrAB ϩ ) into S. Typhimurium and cultured the resulting strains with E. coli EC93 on LB agar. S. Typhimurium targets harboring pZS21-bamA ϩ grew to a 5-fold lower level than cells with the empty plasmid vector ( Fig. 2A) . In principle, this growth inhibition could reflect toxicity from heterologous bamA Ecoli expression. However, S. Typhimurium cells carrying pZS21-bamA ϩ were not inhibited in cocultures with E. coli EC93 ⌬cdiA mutant cells ( Fig. 2A) , indicating that inhibition is due to CDI EC93 . In contrast, S. Typhimurium cells carrying plasmid pacrAB ϩ were not inhibited during coculture with E. coli EC93 (Fig. 2A) . These results suggest that other species are resistant to CDI EC93 because they lack the BamA receptor allele from E. coli. We extended this analysis to E. aerogenes and C. freundii and found that plasmid
mutant cells were mixed with the indicated target species at a 10:1 ratio, and the suspension were incubated on LB agar for 20 h. Cells were harvested, washed, and replated on LB agar supplemented with streptomycin to enumerate viable target cells as CFU. All competitions were conducted at least twice, and the reported values are the mean Ϯ the standard error of the mean.
pZS21-bamA ϩ also sensitizes these bacteria to CDI EC93 ( Fig. 2B  and C) . In each instance, growth inhibition was dependent upon a functional CDI EC93 system and the sensitized bacteria were protected by the expression of a plasmid-borne cdiI EC93 immunity gene ( Fig. 2B and C) . Thus, expression of BamA Ecoli in normally resistant enterobacterial species renders them susceptible to growth inhibition by E. coli EC93.
Heterologous bamA confers CDI EC93 resistance on E. coli. A previous study proposed that the extracellular regions of BamA vary between different species (19) , but the structure of the BamA ␤-barrel domain is unknown. Therefore, we generated a topological model of BamA based on the crystal structure of the homologous FhaC protein from Bordetella pertussis (2) . We then aligned 41 enterobacterial BamA sequences and projected the results onto the topology model as a conservation heat map (Fig. 3A) . Strikingly, the regions of lowest conservation (Յ30% identity) lie within loops 4, 6, and 7, which are the longest of the predicted extracellular loops (Fig. 3A) . In accord with these observations, BamA proteins from E. coli, S. Typhimurium, C. freundii, E. aerogenes, E. cloacae, and P. mirabilis have very diverse loop 4, 6, and 7 regions (see Fig. S2 in the supplemental material). In general, each species has a unique set of BamA loop sequences, but Shigella species and an isolate of Salmonella arizonae have the same loops as E. coli strains.
The predicted BamA topology suggests that extracellular loop polymorphism restricts the E. coli EC93 target cell range. If so, then exchange of bamA Ecoli with bamA genes from other species should protect E. coli cells from CDI EC93 . BamA function is essential for viability (11, 14) ; therefore, we first asked whether such chimeric E. coli strains could be generated. We deleted bamA Ecoli in cells that carry plasmid pZS21-bamA ϩ and then used plasmid exchange to test whether bamA genes from other enterobacteria support E. coli cell viability. E. coli ⌬bamA::cat mutant cells harboring pZS21-bamA ϩ were transformed with plasmid pZS21amp derivatives that contain the same replication origin as pZS21-bamA ϩ but confer resistance to ampicillin. Ampicillin-resistant (Amp r ) transformants were selected and tested for kanamycin resistance (Kan r ) to determine whether plasmid pZS21-bamA ϩ was retained. Retention of the Kan r phenotype indicates that the introduced Amp r plasmid is unable to complement the chromosomal ⌬bamA Ecoli mutation. As a proof of principle, we tested plasmid pZS21amp-bamA ϩ and found that all Amp r transformants were sensitive to kanamycin (see Table S1 in the supplemental material), indicating that plasmid pZS21-bamA ϩ is readily displaced if the incoming plasmid provides BamA function. In contrast, cells transformed with either the empty pZS21amp vector or a construct encoding inactive BamA Ecoli (lacking the POTRA-3 domain) retained plasmid pZS21-bamA ϩ (see Table S1 ). We then tested pZS21amp constructs carrying bamA from other enterobacteria and found that the genes from S. Typhimurium LT2, E. cloacae ATCC 13047, and Dickeya dadantii 3937 all support E. coli ⌬bamA cell viability (see Table S1 ). However, bamA from Yersinia pseudotuberculosis YPIII is unable to complement the E. coli ⌬bamA mutant (see Table S1 ). From these results, we conclude that many, but not all, BamA proteins from other enterobacteria are functional for the biogenesis of E. coli OMPs.
We next tested whether E. coli cells that express heterologous bamA are resistant to CDI EC93 . Target cells complemented with pZS21amp-bamA ϩ were sensitive, sustaining a 3,600-fold decrease in viable cells after 4 h of coculture with E. coli EC93 Competitions between E. coli EC93 and S. Typhimurium target cells carrying plasmid pZS21 or plasmids that express E. coli bamA or acrAB. (B) Competitions between E. coli EC93 and C. freundii cells carrying plasmid pZS21 or pZS21-bamA ϩ . Plasmid pcdiI EC93 corresponds to pDAL741 and constitutively expresses the cdiI immunity gene from E. coli EC93. (C) Competitions between E. coli EC93 and E. aerogenes cells carrying plasmid pZS21, pZS21-bamA ϩ , and/or pcdiI EC93 , as indicated. For all competitions, wild-type E. coli EC93 (cdiA ϩ ) or E. coli EC93 ⌬cdiA mutant cells were cocultured with target bacteria at a 10:1 ratio on LB agar for 20 h. Cells were harvested, washed, and replated on LB agar supplemented with streptomycin for enumeration of viable target cells as CFU. All competitions were conducted at least twice, and the reported values are the mean Ϯ the standard error of the mean.
( Fig. 4A ). In contrast, targets expressing bamA from S. Typhimurium, E. cloacae, or D. dadantii 3937 were resistant to CDI EC93 (Fig. 4A) . However, the latter target strains were inhibited by CdiA-CT EC93 when the toxin was expressed inside the cells from an inducible promoter (see Fig. S4 in the supplemental material). These results argue that CdiA-CT EC93 is not delivered into cells that express heterologous bamA, presumably because CDI EC93 is disrupted at the level of receptor binding. Our previous work has shown that target cells form stable aggregates with inhibitor cells, provided the inhibitors overexpress the CDI EC93 system from a cosmid (1). Furthermore, this aggregation is proportional to BamA Ecoli surface expression on target cells (1), suggesting that cell-cell adhesion reflects the binding interaction between BamA Ecoli and CdiA EC93 . Therefore, we examined adhesion between targets that express the various bamA alleles and inhibitor cells that overexpress CDI EC93 from cosmid pDAL660⌬1-39 (1). Inhibitor cells were labeled with green fluorescent protein (GFP), mixed with DsRed-labeled targets at a 5:1 ratio, and then analyzed by flow cytometry to detect aggregates with both green and red fluorescence. Control experiments showed that 83 Ϯ 1.4% of the targets expressing bamA Ecoli formed aggregates with inhibitor cells (Fig. 4B) . Moreover, this cell-cell adhesion is dependent upon CDI EC93 because mock inhibitors carrying an empty cosmid vector did not aggregate with target cells (Fig. 4B) . Conversely, cells expressing bamA from S. Typhimurium, E. cloacae, or D. dadantii 3937 showed only background levels of aggregation (4 to 6%) with inhibitor cells (Fig. 4B) . Together, these results strongly suggest that CdiA EC93 binds specifically to BamA Ecoli .
Disruption of BamA Ecoli extracellular loops confers resistance to CDI EC93 . To determine whether the predicted extracellular loops are exposed on the cell surface, we examined BamA topology. Three bamA constructs were generated in which nine residues within loops 4, 6, and 7 were replaced with the HA peptide epitope (Fig. 3B) . Each of the HA epitope constructs could displace plasmid pZS21-bamA ϩ from E. coli ⌬bamA::cat cells (see Table S1 in the supplemental material), indicating that the modified BamA proteins are functional and presumably assembled correctly into the outer membrane. We then used immunofluorescence microscopy to examine the surface exposure of HA epitopes. Cells were fixed without permeabilizing the outer membrane, which allows the detection of cell surface antigens but prevents antibody access to periplasmic and cytoplasmic antigens (20) . Immunostaining with anti-HA antibody detected the epitopes within loops 4 and 6 (see Fig. S5 in the supplemental material), indicating that these regions are accessible to antibody and therefore could potentially interact with CdiA EC93 . However, no signal from the loop 7 epitope was detected (see Fig. S5 ). The latter result could indicate that loop 7 is not extracellular, but it is also possible that this region is occluded by another extracellular loop. We next tested whether HA mutations provide resistance to CDI EC93 . Cells expressing bamA 4-HA Ecoli and bamA 6-HA Ecoli were still sensitive to CDI EC93 , but bamA 7-HA Ecoli provided nearly full protection against growth inhibition (Fig. 5A ). This resistance presumably results from a defect in CdiA-CT EC93 delivery, because the strain expressing bamA Ecoli is sensitive to CdiA-CT EC93 toxin produced internally (see Fig. S4 ).
We next generated in-frame deletions to remove loop regions that are unique to the BamA Ecoli receptor (Fig. 3B) . Notably, we were unable to generate the loop 7 deletion, suggesting that this loop may be required for function of the BAM complex. The bamA ⌬4
Ecoli and bamA ⌬6 Ecoli alleles each supported E. coli ⌬bamA::cat cell viability (see Table S1 in the supplemental material), indicating that these loop regions are not required for OMP biogenesis. In competitions with E. coli EC93 cells, targets expressing bamA ⌬4
Ecoli were slightly more resistant than cells expressing wild-type bamA Ecoli , but bamA ⌬6
Ecoli conferred complete resistance (Fig. 5B) . The 7-HA and ⌬loop 6 mutations also disrupted adhesion to inhibitors that overproduce the CDI EC93 system, whereas target cells that express bamA ⌬4
Ecoli still formed aggregates with inhibitors (Fig. 5C ). The latter results correlate with CDI EC93 resistance and implicate BamA Ecoli loops 6 and 7 as important determinants of target cell recognition.
BamA Ecoli extracellular loops 6 and 7 are sufficient for CDI EC93 . The cell-cell adhesion data suggest that BamA Ecoli loops 6 and 7 interact with CdiA EC93 . If so, then these loops should restore sensitivity to CDI EC93 when grafted onto BamA from another species. Chimeric bamA Ecloacae genes were constructed in which individual loop-coding sequences were replaced with the corresponding region from bamA Ecoli (see Fig. S6 in the supplemental material). Each of the single-loop chimeras (bamA Ec4
Ecloacae , bamA Ec6 Ecloacae , and bamA Ec7 Ecloacae ) supported E. coli ⌬bamA::cat cell viability (see Table S1 ). Cells expressing these chimeras were as resistant to CDI EC93 as cells that express bamA Ecloacae (Fig. 6B) , indicating that no single E. coli loop is sufficient for target cell recognition. Similarly, cells expressing bam-A Ecloacae with E. coli loops 4 and 7 were also CDI EC93 resistant. However, cells expressing bamA Ec6/7 Ecloacae , which encodes loops 6 and 7 of E. coli, were almost fully sensitive (Fig. 6B ). The loop 6/7 chimera also supported CDI EC93 -dependent cell-cell adhesion, whereas the other chimeric bamA Ecloacae alleles did not (Fig. 6C) . Together, these results indicate that BamA Ecoli loops 6 and 7 are sufficient for target cell selection during CDI EC93 .
Previous studies have shown that CdiA EC93 is modular and capable of delivering different CdiA-CTs from other systems (8, 20, 21) . This heterologous toxin delivery is dependent upon Bam-A Ecoli (20) , suggesting that specific CdiA-CT sequences are not required for target cell selection. Therefore, we asked whether the chimeric BamA Ec6/7
Ecloacae receptor supports the delivery of other CdiA-CTs into target cells. We tested the previously characterized CdiA EC93 -CT o1 EC93 effector protein, in which the original CdiA-CT EC93 membrane-pore toxin is replaced with a tRNase toxin encoded by the "orphan-1" cdiA-CT o1 EC93 gene from E. coli EC93 (21). CdiA-CT o1 EC93 is an anticodon nuclease (21, 22) ; therefore, we assayed toxin activity by Northern blotting with a probe for E. coli tRNA ICG Arg . We first examined RNA from inhibitor and target cells that had been cultured separately and detected no tRNase activity in either population (Fig. 7A) . However, tRNase activity was observed when inhibitors were cocultured with target cells that express bamA Ecoli (Fig. 7B ). This nuclease activity was not detected when target cells carried a plasmid-borne copy of the cognate cdiI o1 EC93 immunity gene (Fig. 7B) , verifying that the nuclease activity is due to the CdiA-CT o1
EC93 toxin. We next tested targets that express bamA Ecloacae and the various bamA chimeras and detected tRNase activity only in cocultures with inhibitor cells that express bamA Ec6/7 Ecloacae (Fig. 7B ). These results demonstrate that chimeric BamA Ec6/7
Ecloacae supports the delivery of other CDI toxins into E. coli cells.
DISCUSSION
The results presented here show that the CDI system from E. coli EC93 is ineffective against other enteric gammaproteobacterial species. Because CDI-mediated inhibition requires the translocation of protein toxins across the target cell envelope, multiple steps could potentially be disrupted to prevent toxin import into other species. However, our results indicate that cross-species inhibition is blocked primarily at the level of target cell recognition because S. Typhimurium, E. aerogenes, and C. freundii cells become susceptible to CDI EC93 upon the expression of the BamA Ecoli receptor. BamA is conserved between enterobacteria, but three of the predicted extracellular loops contain regions of sequence variability. Two of these variable loops play an important role in target cell selection by E. coli EC93. Perturbations of BamA Ecoli loops 6 and 7 prevent adhesion to inhibitor cells and protect target cells from CDI EC93 -mediated growth inhibition. Moreover, these loops are sufficient for cell-cell adhesion and growth inhibition when grafted onto BamA from another species. The latter observation indicates that loops 6 and 7 together form the CdiA EC93 -binding epitope on E. coli target cells. These data also demonstrate that, given the appropriate receptor, CdiA-CT EC93 toxin can be delivered into other species. This finding underscores previous work showing that CdiA-CTs from Yersinia pestis CO92 and Dickeya dadantii 3937 can be delivered into E. coli cells provided the toxins are fused onto E. coli CdiA proteins (4, 20) . Thus, although the target cell range of a given CDI system may be restricted, CdiACTs appear to possess a general import activity sufficient for translocation into a variety of Gram-negative bacteria.
The clustering of sequence variation within the BamA extracellular loops is striking, but such variability is fairly common with OMPs. These surface-exposed ␤-barrel proteins interact directly with the environment and, as a consequence, are under selective pressure to diversify (23) . OMPs are recognized as antigens by adaptive immune systems and are often exploited as receptors by bacteriophage and bacteriocins. These forces can drive the diversification of a given OMP within an individual bacterial species. For example, extracellular loops 4, 5, and 7 of OmpC vary considerably between E. coli strains, even those isolates that have similar niches and pathogenic lifestyles (24) . In contrast, BamA is almost completely conserved across the hundreds of E. coli strains that have been sequenced to date. Although the extracellular loops of BamA Ecoli are identical in nearly all strains, these regions are subjected to the same selective forces as other OMPs. Shiga-toxinproducing STX phage use BamA as a receptor to infect E. coli cells (19) , and the E. coli EC93 CDI system itself represents a force that could conceivably shape BamA Ecoli evolution. Therefore, BamA conservation between E. coli strains implies that the extracellular loops may be critical for function. Indeed, portions of BamA loop 6 are highly conserved between species and these residues are important for OMP biogenesis (25, 26) . However, our data show that regions within each loop can be mutated extensively and even deleted without loss of viability. In fact, heterologous BamA proteins with alterations in all three loops still support E. coli growth at nearly wild-type rates under laboratory conditions. Therefore, the E. coli-specific extracellular loops are clearly not required for OMP biogenesis, suggesting that other forces act to prevent Bam-A Ecoli diversification. Though the significance of BamA Ecoli conservation is unclear, E. coli EC93 exploits this invariant antigen to target and inhibit closely related competitors.
CDI systems are typically encoded within pathogenicity/ genomic islands and are associated with transposable elements. This linkage to mobile genetic elements suggests that cdi genes are transferred horizontally between bacteria. The finding that certain CdiA-CTs from disparate bacterial species have high sequence identities supports this hypothesis (21) . If such a transfer occurred between unrelated bacteria, then the recipient bacterium would gain an inhibition system that is probably targeted to the donor species. In principle, the newly acquired system could be deployed immediately, but because the donor bacteria are immune to their own CDI toxin, the recipients would gain no competitive advantage over the donor cells. Furthermore, if all CDI systems are self-targeting, then all horizontally transferred cdiA genes must eventually evolve to recognize receptors on the surface of the recipient species. The selective pressures that drive adaptation to selfreceptors are unknown, but perhaps CDI-mediated cell-cell adhesion provides a benefit to bacteria. It is also unclear how cdi genes could be retained during the adaptation process. It is possible that other genes within the transferred genomic island provide a selective advantage and the linked cdi genes could be retained as a result. Alternatively, the toxin/ immunity activities encoded by the cdiA-CT/cdiI pair may stabilize the genomic island in a manner similar to that described for some type II toxin/antitoxin (TA) modules (27, 28) . In the absence of intercellular CdiA-CT exchange, the latter model would require cryptic translation initiation within cdiA to produce cytoplasmic toxin. If cdi genes do indeed stabilize genomic regions in the absence of selection, then it raises the possibility that CDI systems, like TA modules, are encoded by selfish genetic elements that propagate through horizontal transfer.
The target cell range of E. coli EC93 suggests that CDI is used for selfrecognition and could help coordinate multicellular activities. Because CDI EC93 mediates adherence between E. coli cells exclusively, it provides a mechanism for increasing the relatedness of the local population and thus represents a form of "kin selection." Direct interaction between close kin is a common mechanism to increase the fitness of related cells (29) . In accord with this idea, CDI systems enhance biofilm formation in both Burkholderia thailandensis E264 (30) and E. coli EC93 (Z.C.R. and C.S.H., unpublished data). Biofilms require collaboration between individual cells and provide fitness benefits such as protection from predation and antimicrobial agents. These observations indicate that CDI ϩ siblings recognize and cooperate with one another. But CDI ϩ cells also harm CDI Ϫ kin and therefore also act to exclude related cells that lack cdi genes. These phenomena are evocative of so-called "greenbeard" cooperativity (29, 31) . Greenbeard genes give rise to a trait and simultaneously recognize and direct cooperation to other individuals with that same trait (32) . Moreover, greenbeard genes are also sometimes capable of harming others that lack the allele. Individuals that have the same greenbeard alleles need not be related at other genetic loci, and therefore, cooperation occurs between those of the same "kind" and not necessarily between kin. However, different strains of a given species typically harbor distinct CDI toxin/immunity pairs (6), so only closely related bacteria that have identical toxin/immunity alleles are likely to associate and cooperate. Thus, CDI EC93 discriminates kin at two levels-potential collaborators are recognized through specific receptor-binding interactions, and favored siblings are selected by virtue of their immunity gene allele.
MATERIALS AND METHODS
Bacteria and growth conditions. The bacterial strains and plasmids used in this study are listed in Table S2 in the supplemental material. Bacteria were grown in LB broth or LB agar unless otherwise noted. Media were supplemented with antibiotics at the following concentrations: ampicillin, 150 g ml Ϫ1 ; kanamycin, 50 g ml Ϫ1 ; chloramphenicol, 66 g ml Ϫ1 ; spectinomycin, 50 g ml Ϫ1 ; rifampin, 200 g ml Ϫ1 ; streptomycin, 100 g ml Ϫ1 . The bamA gene was replaced with a chloramphenicol acetyltransferase (cat) resistance cassette in E. coli X90 and EPI100 cells carrying plasmids pZS21-bamA ϩ (13) and pSIM6 (33) . The cat gene was amplified with oligonucleotides bamA-cat-for and bamA-cat-rev (see Table S3 in the supplemental material), and the resulting product was electroporated into cells as previously described (33) . Transformants were selected on LB agar supplemented with chloramphenicol at 33 g ml Ϫ1 .
For interspecies competitions, inhibitors and targets were first grown to mid-log phase at 37°C in LB broth supplemented with the appropriate antibiotics. Cells were harvested in M9 salts, and cell densities were determined by measuring optical density at 600 nm (OD 600 ). Inhibitors and targets were then mixed at a 10:1 ratio in M9 salts (to a final OD 600 of 33.0), and 100 l of the cell suspension was plated onto LB agar for incubation at 37°C. After 20 h, cells were harvested into 2 ml of M9 salts. The cell suspensions were serially diluted and plated on LB agar containing the appropriate antibiotics to enumerate viable inhibitor and target cells as colony-forming units (CFU). Intraspecies E. coli competitions were performed in LB broth. The inhibitor and target cells were mixed at a 10:1 ratio (final OD 600 ,~0.330) in LB without antibiotics and cocultured for 3 h at 37°C with vigorous shaking. Samples of the cocultures were removed, serially diluted, and plated onto selective LB agar to enumerate target cells as CFU ml Ϫ1 . CdiA-CT EC93 toxicity was assessed by expression inside E. coli cells from an L-arabinose-inducible promoter on plasmid pCH450 (34) . Plasmids pCH450, pCH450-cdiA-CT EC93 , and pCH450-cdiA-CT/cdiI EC93 were introduced into E. coli X90 ⌬bamA::cat strains carrying the various pZS21-bamA constructs, and the resulting cells were cultured at 37°C in LB medium supplemented with tetracycline and 0.2% L-arabinose. Cell growth was monitored by measuring the OD 600 as a function of time.
Plasmid exchange. E. coli X90 ⌬bamA::cat carrying plasmid pZS21:: bamA ϩ (Kan r ) was transformed with pZS21amp (Amp r ) or pZS21amp derivatives carrying the bamA alleles described above (35) . Transformed cells were incubated for 1 h at 37°C in LB broth, plated onto LB agar supplemented with ampicillin, and then incubated at 37°C for 20 h. Amp r colonies were picked at random and streaked onto fresh LB agar supplemented with ampicillin. The resulting Amp r colonies were then crossstreaked onto separate LB agar plates supplemented with kanamycin or ampicillin. Cell growth on kanamycin and ampicillin was scored after 20 h at 37°C.
Cell-cell adhesion. Overnight cultures of E. coli strain DAL4905 carrying cosmid pDAL660⌬1-39 (CDI ϩ ) or pWEB::TNC (CDI Ϫ ) were diluted into fresh tryptone broth (TB) and grown to mid-log phase at 30°C. These cells were then mixed at a 5:1 ratio with E. coli EPI100 ⌬bamA::cat target cells carrying pZS21-bamA constructs and pDsRedExpress2. The cell suspension was incubated with aeration for 15 min at 30°C, diluted 1:50 into filtered 1ϫ phosphate-buffered saline (PBS), and then analyzed on an Accuri C6 flow cytometer using FL1 (533/30 nm, GFP) and FL2 (585/40 nm, DS-Red) fluorophore filters (Becton Dickinson).
Whole-cell immunofluorescence. Overnight cultures were inoculated into fresh TB containing the appropriate antibiotics and grown to an OD 600 of~0.8. Cells were harvested and fixed for 15 min in 1ϫ PBS supplemented with 4% formaldehyde. Fixation reactions were quenched with 125 mM glycine (pH 7.4). Cells were washed once with 1ϫ PBS supplemented with 125 mM glycine (pH 7.4) and then washed twice with 1ϫ PBS. Washed cells were resuspended in 1ϫ PBS supplemented with 1% bovine serum albumin (BSA) containing a 1:50 dilution of anti-HA monoclonal antibody (Sigma-Aldrich). Cells were incubated for 30 min at room temperature and washed three times with 1ϫ PBS-1% BSA. Washed cells were resuspended in 1ϫ PBS-1% BSA containing a 1:500 dilution of anti-mouse monoclonal antibody conjugated to Alexa Fluor 488 (Invitrogen). Cells were incubated for 30 min on ice and washed thrice with 1ϫ PBS supplemented with 1% BSA. Cells were resuspended in 1ϫ PBS and allowed to adhere to poly-D-lysine-coated slides for 5 min at room temperature. Nonadhering cells were removed with deionized water. Adhering cells were covered and fixed with FluoroGel solution and imaged by fluorescence microscopy.
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FIG 7 BamA Ec6/7
Ecloacae allows delivery of another CdiA-CT. (A) Northern blot analysis of tRNA ICG Arg from E. coli EPI100 carrying cosmid pDAL879 (inhibitors) and E. coli CH9350 (targets). (B) Northern blot analysis of RNA isolated from competition cocultures. Inhibitors were mixed with target cells expressing the indicated bamA alleles at a 1:1 ratio and incubated for 1 h. RNA was isolated from the mixed cultures and analyzed by Northern hybridization using a radiolabeled probe to tRNA ICG Arg . Target cells from the sample on the far right also expressed the cognate cdiI o1 EC93 immunity gene from plasmid pDAL867. Figure S5 , PDF file, 0.2 MB. Figure S6 , PDF file, 0.1 MB. Table S1 , DOCX file, 0.1 MB. Table S2 , DOCX file, 0.1 MB. Table S3 , DOCX file, 0.1 MB.
